**Patient Story: CAR-T Therapy Brings New Hope for Lymphoma Patients – A Case from a Chinese Hospital** In the field of cancer treatment, China has achieved groundbreaking success with CAR-T cell therapy, especially in treating relapsed or refractory lymphoma. Today, we share the story of one patient whose life was transformed through this revolutionary treatment Read More
patient story
**Patient Story | Chinese CAR-T Therapy: An Inspiring Journey of Changing Fate for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)** #CAR-T #DLBCL #Lymphoma #CARTtherapy #RRDLBCL #Patientstory #CD19 In the field of cancer treatment, China has made remarkable strides in CAR-T cell therapy, especially in the fight against relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL). Read More
**The Rise of China’s CAR-T Therapy: New Hope for Multiple Myeloma Patients** #CARTTherapy #CART #MultipleMyeloma #BloodCancer #patientstory China’s CAR-T cell therapy has emerged as a highly effective and proactive option for treating relapsed and refractory multiple myeloma, bringing new hope to patients facing limited treatment options. This innovative therapy has shown significant effectiveness in clinical Read More
China’s CAR-T Therapy: A Beacon of Hope for Children with Acute Lymphoblastic Leukemia (ALL) #CARTTherapy #Leukemia #ChildhoodCancer #ALL #CART #AcuteLymphoblasticLeukemia #Patientstory China’s CAR-T cell therapy is emerging as a beacon of hope in the fight against cancer, bringing unprecedented treatment possibilities. As a precise cellular immunotherapy, CAR-T therapy enhances the cancer-fighting abilities of T-cells through genetic editing technology, Read More
A 62-Year-Old Leukemia Patient in China Receives CAR-T Therapy, Discharged After One Month, and Still Healthy After Five Years! #Leukemia #CAR_Therapy #CancerSurvivor #ChineseHealthcare#PatientStory Acute lymphoblastic leukemia (ALL) is a type of leukemia that originates from B or T lymphoid progenitor cells. Leukemia cells proliferate abnormally in the bone marrow, suppressing normal hematopoiesis, leading to anemia, thrombocytopenia, and Read More
Complete Remission In Just Two Months! China’s CAR-T Therapy Brings New Hope For Lymphoma (DLBCL) Patients! #Lymphoma #CAR_TCellTherapy #DLBCL#CancerHope #PatientStory Lymphoma has long been regarded as a “synonym for death,” with its high incidence and recurrence rates striking fear into many. However, with the rapid advancement of medical technology, a revolutionary new therapy is changing this Read More
The Russian Dancer’s CAR-T Treatment Journey in China: Rekindling Hope for Life #MiraclesOfLife #ChinaCART #CancerTreatment #CancerWarrior #TumorTherapy #patientstory #lymphoma CAR-T cell therapy is a groundbreaking cancer treatment that harnesses the patient’s own immune system by engineering T cells to recognize and attack cancer cells. In recent years, this therapy has brought new hope to patients Read More
**The Miracle of CAR-T Therapy in China: Mrs. Li’s Battle Against Lymphoma** In the long journey of life, cancer often strikes like a sudden storm, leaving patients and their families devastated. Mrs. Li, a young and resilient mother from China, was no exception. Two years ago, she was diagnosed with relapsed and refractory B-cell non-Hodgkin Read More
### The Courage to Be First: China’s CAR-T Pioneer, “Emily of China,” Celebrates 6 Years in Complete Remission! #CART #PatientStory #lymphoma #TP53 #DLBCL #CARTTherapy Meet Mrs. Qin, a true fighter and the first brave patient in China to receive Fosun Kite’s Axicabtagene Ciloleucel in a CAR-T clinical trial. Her story is one of hope, perseverance, Read More
**Иностранные пациенты ищут лечение: Лучшая терапия CAR-T в Китае! Первый российский пациент с множественной миеломой успешно очистил опухоль и достиг CR!** В течение пяти лет после постановки диагноза высокорисковой множественной миеломы, господин Ф. испытывал невыносимые страдания. Несмотря на различные схемы химиотерапии и два пересадок, ему не удавалось полностью избавиться от кошмара непредсказуемых рецидивов и прогрессирования Read More
**Seeking Medical Treatment Abroad: The Best CAR-T Therapy is in China! The First Russian Multiple Myeloma Patient Successfully Achieves Complete Tumor Clearance and CR!** Over the five years following his diagnosis of high-risk multiple myeloma, Mr. F endured relentless pain. Despite undergoing various chemotherapy regimens and two transplants, he could never completely escape the nightmare Read More
Celebrating Discharge: The Joy of a New Life/ Hope /Multiple myeloma After a period of treatment, the Singaporean patient Teresa achieved remarkable results with CAR-T therapy at Jiahui International Hospital in Shanghai. Her condition reached complete remission (CR), and to celebrate this great news, the hospital held a brief yet heartwarming celebration for her. Read More